CFDE Data Portal | Search S100P

	Label	Description
	S100P Gene (Entity type)	ENSG00000163993 - S100 calcium binding protein P
	PLOD3 Gene (Entity type)	ENSG00000106397 - procollagen-lysine,2-oxoglutarate 5-dioxygenase 3
	ARGLU1 Gene (Entity type)	ENSG00000134884 - arginine and glutamate rich 1
	CMPK1 Gene (Entity type)	ENSG00000162368 - cytidine/uridine monophosphate kinase 1
	SLC35A3 Gene (Entity type)	ENSG00000117620 - solute carrier family 35 member A3
	ECH1 Gene (Entity type)	ENSG00000104823 - enoyl-CoA hydratase 1
	KCNMB1 Gene (Entity type)	ENSG00000145936 - potassium calcium-activated channel subfamily M regulatory beta subunit 1
	GSE216043 7 V 9 CISPLATIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE205729,GSE205731 2 V 3 TAZEMETOSTAT HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE216043 10 V 5 CISPLATIN HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS

S100P

ENSG00000163993 - S100 calcium binding protein P

PLOD3

ENSG00000106397 - procollagen-lysine,2-oxoglutarate 5-dioxygenase 3

ARGLU1

ENSG00000134884 - arginine and glutamate rich 1

CMPK1

ENSG00000162368 - cytidine/uridine monophosphate kinase 1

SLC35A3

ENSG00000117620 - solute carrier family 35 member A3

ECH1

ENSG00000104823 - enoyl-CoA hydratase 1

KCNMB1

ENSG00000145936 - potassium calcium-activated channel subfamily M regulatory beta subunit 1

GSE216043 7 V 9 CISPLATIN HUMAN DN

A Gene Set from LINCS

GSE205729,GSE205731 2 V 3 TAZEMETOSTAT HUMAN UP

A Gene Set from LINCS

GSE216043 10 V 5 CISPLATIN HUMAN UP

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.